Virax Biolabs Group Ltd. (VRAX)
2.83
+0.10
(+3.66%)
USD |
NASDAQ |
Sep 10, 14:58
Virax Biolabs Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Interpace Biosciences, Inc. | 0.0419 |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| Fresenius SE & Co. KGaA | 0.5796 |
| Rafina Innovations, Inc. | -- |